An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 18 April 2013.
If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.
Opposition Proceedings
Opposition Lodged
No additional applications for opposition have been lodged.
Opposition Withdrawn
Opposition to acceptance of the following applications has been withdrawn and the application shall proceed to sealing:
| Application No. | Title | Applicant(s) | Opponent(s) | ||
| 2006218936 | Shoulder implant for glenoid replacement and methods of use thereof | Shoulder Innovations, LLC | Ascension Orthopedics, Inc. | ||
| 2008269556 | Reduced fat chocolate | Cadbury Holdings Limited | Mars, Incorporated | ||
Opposition Dismissed
No additional opposition proceedings have been dismissed.
Applications Withdrawn
The following applications for opposition have been withdrawn:
| Application No. | Title | Applicant(s) | Opponent(s) | ||
| 2008201605 | Palatable ductile chewable veterinary composition | Novartis AG | Merial Ltd | ||
| 2011200206 | Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease | The Kennedy Institute of Rheumatology | Abbott Bioresearch Centre | ||
Extensions of Term of Standard Patents
Applications Filed
The following application(s) for Extension of Term under Section 70 have been filed:
| Patent No | Title | Applicant | Approval Date & Goods | Expiry Date |
| 2005237266 | Pharmaceutical compositions | Vectura Limited | 12 Nov 2012
For the goods SEEBRI BREEZHALER glycopyrronium (as bromide) |
12 Nov 2027 |
Applications Accepted
No additional application(s) for Extension of Term have been accepted under Section 74.
Applications Refused
No additional application(s) for Extension of Term have been refused.
Extensions granted
The following application(s) for Extension of Term have been granted under Section 76:
| Patent No | Title | Applicant | Approval Date & Goods | Expiry Date |
| 2004287601 | Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations | Alfa Wassermann S.p.A. | 17 May 2012 For the goods XIFAXAN rifaximin | 17 May 2027 |
| 2006261993 | Pyrrolo (2, 3-B) pyridine derivatives as protein kinase inhibitors | Plexxikon, Inc. | 10 May 2012 For the goods ZELBORAF vemurafenib | 10 May 2027 |
Surrendered and Revoked Letters Patent
Surrendered Letters Patent
No patents have been offered for surrender:
Revocation of Letters Patent
No patents have been wholly or partially revoked: